Abstract
A long-term goal of treating coronary artery disease (CAD) is to decrease mortality by reducing the prevalence of myocardial infarction (MI) and sudden cardiac death. An immediate goal of treatment is to minimize chest pain (coronary pain, angina), increase physical tolerance, and to positively influence the quality of life (QoL) of patients by alleviating symptoms [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hlatky MA (2004) Coronary revascularization and quality of life. Am Heart J 148:5–6
Bertuccio P, Levi F, Lucchini F et al (2011) Coronary heart disease and cerebrovascular disease mortality in young adults: recent trends in Europe. Eur J Cardiovasc Prev Rehabil 18:627–634
Rodríguez T, Malvezzi M, Chatenoud L et al (2006) Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970–2000. Heart 92:453–460
Mommersteeg PM, Denollet J, Spertus JA, Pedersen SS (2009) Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J 157: 208–218
Xie J, Wu EQ, Zheng Z-J et al (2008) Patient-reported health status in coronary heart disease in the United States. Age, sex, racial and ethnic differences. Circulation 118:491–497
Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31:2501–2555
Bucher HC, Hengstler P, Schindler C, Guyatt GH (2000) Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ 321:73–77
Benzer W, Hofer S, Oldridge NB (2003) Health-related quality of life in patients with coronary artery disease after different treatments for angina in routine clinical practice. Herz 28:421–428
Westin L, Nilstun T, Carlsson R, Erhardt L (2005) Patients with ischemic heart disease: quality of life predicts long-term mortality. Scand Cardiovasc J 39:50–54
Folland ED, Hartigan PM, Parisi AF (1997) Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Vetrenas Affairs Cooperative randomized trial. Veterans Affairs ACME Investigators. J Am Coll Cardiol 29:1505–1511
Spertus JA, Salisbury AC, Jones PG et al (2004) Predictors of quality-of-life benefit after percutaneous coronary intervention. Circulation 110:3789–3794
Boden WE, O’Rourke RA, Teo KK et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 35:1503–1516
Weintraub WS, Spertus JA, Kolm P et al (2008) Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359:677–687
Peterson ED, Rumsfeld JS (2008) Finding the Courage to reconsider medical therapy for stable angina. N Engl J Med 359:751–753
Holubkov R, Laskey WK, Haviland A et al (2002) Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic registry. Am Heart J 144:826–833
Rihal CS, Raco DL, Gersh BJ, Yusuf S (2003) Indications for coronary artery bypass surgery and percutaneous coronary interventions in chronic stable angina: review of the evidence and methodological considerations. Circulation 108:2439–2455
Permanyer-Miralda G, Alonso J, Brotons C et al (1999) Perceived health over 3 years after percutaneous coronary balloon angioplasty. J Clin Epidemiol 52:615–623
Pocock SJ, Henderson RA, Seed A et al (1996) Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery: 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation 94:135–142
Nash IS, Curtis LH, Rubin H (1999) Predictors of patient-reported physical and mental health 6 months after percutaneous coronary revascularization. Am Heart J 138:422–429
de Quadros AS, Lima TC, Rodrigues AP et al (2011) Quality of life and health status after percutaneous coronary intervention in stable angina patients: results from the real-world practice. Catheter Cardiovasc Interv 77:954–960
The TIME Investigators (2001) Trial of Invasive versus Medical Therapy in Elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomized trial. Lancet 358:951–957
Buser MA, Buser PT, Kuster GM et al (2008) Improvements in physical and mental domains of quality of life by anti-ischaemic drug and revascularization treatment in elderly men and women with chronic angina. Heart 94:1413–1418
Henderson RA, Pocock SJ, Clayton TC et al (2003) Seven-year outcome in the RITA-2 trial trail: coronary angioplasty versus medical therapy. J Am Coll Cardiol 42:1161–1170
Pfisterer M for the TAIM Investigators (2004) Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy. Four-year follow-up of the Randomized Trial of Invasive versus Medical Therapy in Elderly Patients (TIME). Circulation 110:1213–1218
Seto TB, Taira DA, Berezin R et al (2000) Percutaneous coronary revascularization in elderly patients: impact on functional status and quality of life. Ann Intern Med 132:955–958
Li R, Yan BP, Dong M et al (2012) Quality of life after percutaneous coronary intervention in the elderly with acute coronary syndrome. Int J Cardiol 155:90–96
Schenkeveld L, Pedersen SS, Nierop JWI et al (2010) Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention. Am Heart J 159:471–476
Pedersen SS, Versteeg H, Denollet J et al (2011) Patient-rated health status predicts prognosis following percutaneous coronary intervention with drug-eluting stentiong. Qual Life Res 20:559–567
Park D-W, Yun S-C, Lee S-W et al (2008) Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 117:2079–2086
Hlatky MA, Boothroyd DB, Melsop KA et al (2004) Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation 110:1960–1966
Zhang Z, Mahoney EM, Stables RH et al (2003) Disease-specific health status following stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: 1-year results from the Stent or Surgery trial. Circulation 108:1694–1700
Favarato ME, Hueb W, Boden WE et al (2007) Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial. Intern J Cardiol 116:364–370
Serruys PW, Unger F, Sousa E et al (2001) Comparison of coronary-artery-bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344:1117–1124
Zhang Z, Weintraub WS, Mahoney EM et al (2004) Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary artery disease in women versus men (one-year results from the Stent or Surgery Trial). Am J Cardiol 93:404–409
Serruys PW, Ong ATL, Morice M-C et al (2005) Arterial Revascularisation Therapies Study Part II — sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 1:147–156
Daemen J, Kuck KH, Macaya C et al (2008) Multivessel coronary revascularization in patients with and without diabetes mellitus. J Am Coll Cardiol 52:1957–1967
van Domburg RT, Daemen J, Morice MC et al (2010) Short-and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. Euro Intervention 5:962–967
Cohen DJ, Van Hout B, Serruys PW et al (2011) Synergy between PCI with Taxus and Cardiac Surgery Investigators. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med 364:1016–1026
Kapetanakis EI, Stamou SC, Petro KR et al (2008) Comparison of the quality of life after conventional versus off-pump coronary artery bypass surgery. J Card Surg 23:120–125
Navia D, Vrancic M, Vaccarino G et al (2008) Total arterial off-pump coronary revascularization using bilateral thoracic arteries in triple-vessel disease: surgical technique and clinical outcomes. Ann Thorac Surg 86:524–530
Dias CC, Mateus P, Santos L et al (2005) Acute coronary syndrome and predictors of quality of life. Rev Port Cardiol 24:819–831
Janzon M, Levin LA, Swahn E (2004) Invasive treatment in unstable coronary artery disease promotes health-related quality of life: results from the FRISC II trial. Am Heart J 148:112–119
Kim J, Henderson RA, Pocock SJ et al (2005) Health-related quality of life after inteventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction. One-year results of the Third Randomized Intervention Trial of Unstable Angina (RITA-3). J Am Coll Cardiol 45:221–228
Ho MP, Eng MH, Rumsfeld JS et al (2008) The influence of age on health status outcomes after acute myocardial infarction. Am Heart J 155:855–861
Shah P, Najafi AH, Panza JA et al (2009) Outcomes and quality of life in patients ≥ 85 years of age with ST-elevation myocardial infarction. Am J Cardiol 103:170–174
Thombs BD, Ziegelstein RC, Stewart DE et al (2008) Usefulness of persistent symptoms of depression to predict physical health status 12 months after an acute coronary syndrome. Am J Cardiol 101:15–19
Van de Werf F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 29:2909–2945
Thombs BD, Ziegelstein RC, Stewart DE et al (2008) Physical health status assessed during hospitalization for acute coronary syndrome predicts mortality 12 month later. J Psychosom Res 65:587–593
Peterson PN, Spertus JA, Magid JD et al (2006) The impact of diabetes on one-year health status outcomes following acute coronary syndromes. BMC Cardiovasc Dis 6:41
Hochman JS, Sleeper LA, White HD et al (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285:190–192
Sleeper LA, Ramanathan K, Picard MH et al (2005) Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 46:266–273
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Bryniarski, L., Klocek, M. (2013). Quality of Life in Patients After Coronary Interventional Treatment. In: Kawecka-Jaszcz, K., Klocek, M., Tobiasz-Adamczyk, B., Bulpitt, C.J. (eds) Health-Related Quality of Life in Cardiovascular Patients. Springer, Milano. https://doi.org/10.1007/978-88-470-2769-5_4
Download citation
DOI: https://doi.org/10.1007/978-88-470-2769-5_4
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2768-8
Online ISBN: 978-88-470-2769-5
eBook Packages: MedicineMedicine (R0)